secwatch.observer — SEC 8-K summary
======================================

Issuer:     SERA PROGNOSTICS, INC. (SERA)
CIK:        0001534969
Form:       8-K
Filed at:   2022-04-12T23:59:59+00:00
Accession:  0001534969-22-000048
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sera Prognostics appoints Dr. Jane F. Barlow to Board of Directors
------------------------------------------------------------------

- Dr. Jane F. Barlow appointed as Class I Director effective April 11, 2022; term expires at 2022 annual meeting.
- Dr. Barlow brings experience from CVS Health, Medco, and boards of ContraFect, Viracta, Point Health.
- Granted non-qualified stock option with $240,000 grant date fair value, vesting monthly over 36 months.
- Entitled to annual cash retainer of $35,000 for non-employee director service, prorated.
- Company entered into standard indemnification agreement with Dr. Barlow.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534969/000153496922000048/0001534969-22-000048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534969/000153496922000048/sera-20220411.htm
  HTML page:      https://secwatch.observer/filing/0001534969-22-000048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer